[Federal Register: February 20, 2003 (Volume 68, Number 34)]
[Notices]
[Page 8299-8300]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr20fe03-68]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Contaminants and Natural Toxicants Subcommittee of the Food
Advisory Committee; Notice of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public.
Name of Committee: Contaminants and Natural Toxicants Subcommittee
of the Food Advisory Committee.
General Function of the Committee: To provide advice and
recommendations to the agency on FDA's regulatory issues.
Date and Time: The meeting will be held on March 18, 2003, from 8
a.m. to 6 p.m.; and on March 19, 2003, from 8:30 a.m. to 3 p.m.
Location: U.S. Department of Agriculture, Animal and Plant Health
Inspection Service, 4700 River Rd., Conference Center, Riverdale, MD,
301-734-8010.
Contact Person: Jeanne E. Latham, Center for Food Safety and
Applied Nutrition (HFS-800), Food and Drug Administration, 5100 Paint
Branch Pkwy., College Park, MD 20740, 301-436-1756, or FDA Advisory
Committee Information Line, 1-800-741-8138 301-443-0572 in the
Washington, DC area), code 10564. Please call the Information Line for
up-to-date information on this meeting.
Agenda: The meeting's purpose is to discuss the scientific issues
and principles involved in assessing and evaluating Enterobacter
sakazakii contamination in powdered infant formula, risk reduction
strategies based on available data, and research questions and
priorities. To ensure the presence of the most relevant expertise, the
membership of the subcommittee, which has expertise in contaminants,
will be augmented by consultants with expertise in infant formula.
The background material for this meeting will be posted on the
Internet when available or one working day before the meeting at http://www.cfsan.fda.gov/
[sim]lrd/vidtel.html.
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person by March 3, 2003.
Oral
[[Page 8300]]
presentations from the public will be scheduled between approximately 4
p.m. and 5 p.m. on March 18, 2003. Time allotted for each presentation
may be limited. Those desiring to make formal oral presentations should
notify the contact person before March 13, 2003, and submit a brief
statement of the general nature of the evidence or arguments they wish
to present, the names and addresses of proposed participants, and an
indication of the approximate time requested to make their
presentation.
Persons attending FDA's advisory committee meetings are advised
that the agency is not responsible for providing access to electrical
outlets.
FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
physical disabilities or special needs. If you require special
accommodations due to a disability, please contact Jeanne E. Latham at
least 7 days in advance of the meeting.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: February 10, 2003.
Linda Arey Skladany,
Associate Commissioner for External Relations.
[FR Doc. 03-4089 Filed 2-19-03; 8:45 am]
BILLING CODE 4160-01-S
Infant Formula
|
Public Meetings, Advisory Committees, and
Dockets Management
Foods Home
|
FDA Home
|
HHS Home
|
Search/Subject Index
|
Disclaimers & Privacy Policy
|
Accessibility/Help